Aberrant upregulation of the glycolytic enzyme PFKFB3 in CLN7 neuronal ceroid lipofuscinosis.
Aberrant upregulation of the glycolytic enzyme PFKFB3 in CLN7 neuronal ceroid lipofuscinosis.
复制标题
DOI:
10.1038/s41467-022-28191-1
复制
发表时间:
2022-01-27
影响因子:
16.6
通讯作者:
Bolaños JP
中科院分区:
文献类型:
--
作者:
Lopez-Fabuel I;Garcia-Macia M;Buondelmonte C;Burmistrova O;Bonora N;Alonso-Batan P;Morant-Ferrando B;Vicente-Gutierrez C;Jimenez-Blasco D;Quintana-Cabrera R;Fernandez E;Llop J;Ramos-Cabrer P;Sharaireh A;Guevara-Ferrer M;Fitzpatrick L;Thompton CD;McKay TR;Storch S;Medina DL;Mole SE;Fedichev PO;Almeida A;Bolaños JP
CLN7 neuronal ceroid lipofuscinosis is an inherited lysosomal storage neurodegenerative disease highly prevalent in children. CLN7/MFSD8 gene encodes a lysosomal membrane glycoprotein, but the biochemical processes affected by CLN7-loss of function are unexplored thus preventing development of potential treatments. Here, we found, in the Cln7∆ex2 mouse model of CLN7 disease, that failure in autophagy causes accumulation of structurally and bioenergetically impaired neuronal mitochondria. In vivo genetic approach reveals elevated mitochondrial reactive oxygen species (mROS) in Cln7∆ex2 neurons that mediates glycolytic enzyme PFKFB3 activation and contributes to CLN7 pathogenesis. Mechanistically, mROS sustains a signaling cascade leading to protein stabilization of PFKFB3, normally unstable in healthy neurons. Administration of the highly selective PFKFB3 inhibitor AZ67 in Cln7∆ex2 mouse brain in vivo and in CLN7 patients-derived cells rectifies key disease hallmarks. Thus, aberrant upregulation of the glycolytic enzyme PFKFB3 in neurons may contribute to CLN7 pathogenesis and targeting PFKFB3 could alleviate this and other lysosomal storage diseases. CLN7 neuronal ceroid lipofuscinosis is an inherited lysosomal storage disease typically with childhood onset of neurodegenerative symptoms. Here the authors report that in a mouse model of CLN7 disease neuronal reactive oxygen species and the activity of glycolytic enzyme PFKFB3 are increased, while PFKFB3 inhibition ameliorates hallmarks of pathology.
登录
查看更多内容
影响因子:
3.5
作者:
Brandenstein, Laura;Schweizer, Michaela;Storch, Stephan
通讯作者:
Storch, Stephan
影响因子:
21.3
作者:
Herrero-Mendez, Angel;Almeida, Angeles;Bolanos, Juan P.
通讯作者:
Bolanos, Juan P.
影响因子:
14.5
作者:
Kousi, Maria;Siintola, Eija;Lehesjoki, Anna-Elina
通讯作者:
Lehesjoki, Anna-Elina
影响因子:
3.9
作者:
Aiello, Chiara;Terracciano, Alessandra;Santorelli, Filippo M.
通讯作者:
Santorelli, Filippo M.
影响因子:
4.1
作者:
LARRABEE, MG
通讯作者:
LARRABEE, MG